Stockreport

Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial

Tenax Therapeutics, Inc.  (TENX) 
Last tenax therapeutics, inc. earnings: 11/14 04:31 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.tenaxthera.com
PDF 15 patients have been randomized83% initial response rate to qualify for randomizationPulmonary capillary wedge pressure (PCWP) was reduced , on average, by 8 mmHg durin [Read more]